You are here
- Home
- Therapy Areas
- Respiratory/Inflammation
Phase I, Single Centre, Double-blind, Randomised, Placebo-controlled, Parallel-group Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Inhaled AZD5423 after Administration of Multiple Ascending Doses for 14 days in Healthy Male and Female Subjects
- Disease
- asthma
- Drug Name
- AZD5423
- Generic Name
- AZD5423
- Sponsor
- AstraZeneca
- Drug Status
- In Development
- Phase
- I
- Start Date
- Jan 18, 1971
- Study Name
- D2340C00002
- Study Id
- D2340C00002
- ClinicalTrials.gov ID
- NCT01037504
- Recruiting Status
- Closed
- Protocol Status
- Not Available
- Report Status
- Not Available
